News

Targeted Oncology22h
Patient Factors Determine Treatment Selection for PD-L1 Negative NSCLC
During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...
C&EN25d
Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma
Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, especially the most malignant proximal-proliferative subtype without ...
IEEE26d
Investigation of Sub-Centimeter Lung Nodule Quantification for Low-Dose PET
Abstract: With the recent development of high resolution time-of-flight (TOF) positron emission tomography (PET) and resolution recovery incorporated in the reconstruction algorithm, accurate ...
IEEE1mon
Automated method for extraction of lung tumors using a machine learning classifier with knowledge of radiation oncologists on data sets of planning CT and FDG-PET/CT images
Second, six voxel-based features including voxel values and magnitudes of image gradient vectors were derived from each voxel in the planning CT and PET /CT image data sets. Finally, lung tumors were ...
thorax.bmj1mon
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
17 Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, UK Correspondence to Professor Nick A Maskell, Academic Respiratory Unit, Bristol Medical School, University of ...
KCCI Des Moines1mon
FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US
The data showed that 91.7% of adults with positive results using the blood test had the presence of amyloid plaques confirmed by their PET scan or cerebrospinal fluid test, and 97.3% of people ...